Acetyl-L-carnitine in the treatment of chronic lumbar radiculopathy pain
Includes GLP-1 SG 10mg, Tesamorelin 10mg, NAD+ Buffered 500mg, and BAC Water 10mL bundled together at discounted pricing
The medication demonstrates substantial efficacy in reducing hemoglobin A1c levels and promoting weight loss, with reductions of up to 21% of body weight observed in clinical trials of patients with obesity without diabetes, and approximately 12-15% in those with type 2 diabetes
Retatrutide is an investigational weight-loss and metabolic medicine being developed by Eli Lilly
After completing a treatment cycle, taking 2 to 4 weeks off before potentially repeating allows assessment of maintained improvements
American pharmaceutical firm Eli Lilly similarly sought to halt compounded versions of its drugs Mounjaro and Zepbound, intended for diabetes and obesity treatment